Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00483028
Status:
COMPLETED
Last Update Posted:
2008-02-05
First Post:
2007-06-05
Brief Title:
A Randomized Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Randomized Double-Blind Parallel Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil 5 mg QD for 6 Weeks After Single Dose and Steady State Therapy 2 Weeks and 6 Weeks in Subjects With Mild Cognitive Impairment
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To purpose of this study is to estimate the effect of donepezil on Neuropsychological Testing NPT and brain Proton Magnetic Resonance Spectroscopy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None